The NaBu Effect on Menstruation in Women
ConditionMenstrual Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMagdy Milad, MD
About this trial
The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.
Eligibility criteria
Qualifiers
18 years or older.
Menstruating regularly or irregularly
Experiencing menstrual symptoms with an average baseline symptom score of at least 3 on a scale of 0 to 10 for at least one symptom during the initial pre-study rating period.
Disqualifiers
Pregnant or breastfeeding patient, attempting or anticipating pregnancy.
Patient with a history of bloating or a sensitive gut (food intolerance) who needs lower fiber levels.
Patients with known lactose intolerance, other fermentable oligo-, di-, and mono-saccharides, and polyols (FODMAP) intolerances, or small intestinal bacterial overgrowth (SIBO).
Patients who would require taking daily antacids for the duration of the study.
Trial design
Treatments tested in this trial
- Sodium Butyrate (NaBu)
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Magdy Milad, MD
Lead sponsor
Northwestern University
Sponsor institution
Source ClinicalTrials.gov